Fmoc-Thr(GlcNAc(Ac)3-b-D)-OH

CAS No. 160168-40-1

Fmoc-Thr(GlcNAc(Ac)3-b-D)-OH( —— )

Catalog No. M21715 CAS No. 160168-40-1

This amino acid is compatible with standard protocols in Fmoc solid phase peptide synthesis. Following chain assembly.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 276 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Fmoc-Thr(GlcNAc(Ac)3-b-D)-OH
  • Note
    Research use only, not for human use.
  • Brief Description
    This amino acid is compatible with standard protocols in Fmoc solid phase peptide synthesis. Following chain assembly.
  • Description
    This amino acid is compatible with standard protocols in Fmoc solid phase peptide synthesis. Following chain assembly, removal of the acetyl protecting group can be carried out by treatment of the peptidyl resin with methanolic ammonia or sodium methoxide/DMF/methanol, or by treatment of the cleaved peptide with catalytic sodium methoxide in methanol.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    160168-40-1
  • Formula Weight
    670.66
  • Molecular Formula
    C33H38N2O13
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Phenothrin

    Phenothrin, also called sumithrin, is a synthetic pyrethroid that kills adult fleas and ticks. It has also been used to kill head lice in humans.

  • Isopropylidenylacety...

    Isopropylidenylacetyl-marmesin is a natural product derived from the roots of Notopterygium incisum and Ferulago bracteata.

  • GSK-626616

    GSK-626616 is a potent and orally bioavailable DYRK3 inhibitor (IC50: 0.7 nM). It inhibits other members of the DYRK family with similar potency. GSK-626616 is a potential therapy for the treatment of anemia.